Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLD [NA]
A completed clinical trial evaluated whether tomato consumption influences liver steatosis, intestinal function, and glucose/lipid metabolis…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Dietary Allowance of Methyl Donor Nutrients to Minimize Risks of Non-alcoholic Fatty Liver Progression [NA]
A completed clinical trial evaluated whether dietary intake of methyl donor nutrients can reduce the risk of progression in non-alcoholic fa…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD) [Phase 1]
Phase 1 trial of LY3885125 in participants with dyslipidemia and non-alcoholic fatty liver disease was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: FibroScan-Reproducibility and Repeatability Study [NA]
A completed clinical trial assessing the reproducibility and repeatability of FibroScan measurements in patients with non-alcoholic fatty li…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Microbiome-Mediated Gut Dysfunction in Non-Alcoholic Fatty Liver Disease
This ClinicalTrials.gov entry reports a completed study examining microbiome-mediated gut dysfunction in non-alcoholic fatty liver disease.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules [Phase 4]
Phase 4 trial comparing Ornithine Aspartic Acid Granules to Silymarin Capsules in non-alcoholic fatty liver disease completed, assessing eff…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Diagnosis of Fatty Liver With Outpatient Ultrasound
Recruiting is ongoing for a clinical study evaluating outpatient ultrasound to diagnose fatty liver (liver steatosis).
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD
This completed clinical trial evaluated the relationship between hepatic fibrosis and cardiovascular risk in patients with non-alcoholic fat…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH [Phase 1, Phase 2]
A completed phase 1/2 clinical trial sponsored by Chuncheon Sacred Heart Hospital evaluated the effects of probiotic strains Pediococcus pen…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Ketotifen in Non-Alcoholic Fatty Liver Disease Patients [Phase 4]
Ketotifen was studied in patients with non-alcoholic fatty liver disease in a Phase 4 trial. The study has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: Study to Investigate the Effect of L. Lactis CKDB001 Administration on Liver Aminotransferases in Subjects With NAFLD [NA]
This trial update reports the completion of a study evaluating the effect of the probiotic L. lactis CKDB001 on liver aminotransferase level…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Pediatric Liver Fat Quantification (LFQ) Phase 2 Pilot Study [NA]
A Phase 2 pediatric pilot trial evaluating liver fat quantification (LFQ) has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Milk Thistle Clinical Trial in Pediatric NAFLD [Phase 2]
A Phase 2 clinical trial evaluating milk thistle in pediatric non-alcoholic fatty liver disease is currently recruiting, sponsored by Univer…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study [NA]
A completed pilot trial evaluating ultrasound-based liver fat quantification for non-alcoholic fatty liver disease and non-alcoholic steatoh…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Comparative Effects of Aspirin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver Disease [NA]
A completed study compared the effects of aspirin versus SGLT2 inhibitors on liver enzymes, lipid profile, and FibroScan findings in individ…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Pancreatic Clamp in NAFLD [Phase 1]
Phase 1 clinical trial evaluating a pancreatic clamp approach in non-alcoholic fatty liver disease to study insulin resistance and related m…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Glycemic Effect of Diazoxide in NAFLD [Phase 1]
A Phase 1 study evaluating the glycemic effects of diazoxide in individuals with hyperinsulinemia, insulin resistance, prediabetes, and non-…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: A Clinical Trial of Longqi Jiangzhi Decoction Against Non-alcoholic Fatty Liver Disease [Phase 2]
A Phase 2 clinical trial is evaluating Longqi Jiangzhi Decoction for non-alcoholic fatty liver disease and is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Diagnostic Accuracy of the "LLIFT", a Novel Non-invasive Biomarker for the Diagnosis of Non Alcoholic Fatty Liver (NAFL) and SteatoHepatitis (NASH) in a Population With High Risk of Metabolic Syndrome"
This completed trial assesses the diagnostic accuracy of LLIFT, a novel non-invasive biomarker, for diagnosing non-alcoholic fatty liver dis…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology. [NA]
A completed clinical trial (sponsored by Hospices Civils de Lyon) evaluating screening for NAFLD-related advanced fibrosis in a high-risk di…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Saroglitazar Magnesium 4 mg in the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Women With PCOS (EVIDENCES VII) [Phase 2]
Phase 2 trial of Saroglitazar Magnesium 4 mg for non-alcoholic fatty liver disease in women with polycystic ovary syndrome (PCOS) was termin…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes
Clinical trial evaluating whether SGLT2 inhibitor therapy affects elastographic and molecular markers of liver injury in patients with type …
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Assessment of Hepatic Steatosis Using Dedicated Software Implemented on Ultrasound Devices
A completed clinical trial evaluating hepatic steatosis assessment using dedicated ultrasound software implemented on ultrasound devices.
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease [Phase 1]
Phase 1 study evaluating tolerability of multiple doses of BI 3006337 in adults with obesity and non-alcoholic fatty liver disease; the tria…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Repeatability and Reproducibility of Multiparametric MRI
A clinical trial update reports on the repeatability and reproducibility of multiparametric MRI for evaluating liver diseases across several…